The government has temporarily “re-opened” until Feb 15th after the longest government shutdown in US history that lasted for 35 days.
Here’s what’s going to happen...
COBRAhealth.com - The Patient Protection and Affordable Care Act, PPACA. The government cannot create doctors, nurses and facilities to service the masses of people. ObamaCare cuts payments to the private health insurance companies that provide coverage to the 20 percent of Medicare enrollees who participate in the Medicare Advantage program.ObamaCare cuts the prices Medicare uses to pay hospitals and many other health care providers. ObamaCare could force one in six hospitals to stop accepting Medicare patients. we will ration with our eyes open.You can't get medications. You are left waiting on life saving procedures. You must wait for quality of life procedures that are medically needed. 5 million Canadians have no health insurance and the wait is 5 years for a primary care physician.
What the Government Shutdown Means to the Med Device Industry?EMMAIntl
On December 22nd, 2018, the Federal Government went into a partial shutdown. Forty one percent of the FDA staff has been furloughed, which means that out of 17,397 FDA staff members, only 10,344 members have been retained for work. The number of furloughed employees may increase as the shutdown progresses...
Safer Technologies Program for Medical DevicesEMMAIntl
FDA has introduced a new program for medical devices and for device led combination products. Under this program are devices that do not qualify to be cleared via the breakthrough program but significantly improve the safety of the currently available options that treat diseases that are non-life threatening...
NEMEA\'s library of authority documents. To create a survey or audit, log into the Compliance Centre, select the type of audit and choose your authority document. It could not be easier!
Whenever there is a public health emergency, such as the Zika virus in 2016 or the current novel coronavirus, there is a rush to get diagnostic tests and other medical products to detect and treat the emergency available quickly. Given that dealing with the FDA isn’t usually a quick transaction, there is a provision in place called the Emergency Use Authorization (EUA) which allows the use of unapproved medical products when there are no other adequate or available alternatives...
COBRAhealth.com - The Patient Protection and Affordable Care Act, PPACA. The government cannot create doctors, nurses and facilities to service the masses of people. ObamaCare cuts payments to the private health insurance companies that provide coverage to the 20 percent of Medicare enrollees who participate in the Medicare Advantage program.ObamaCare cuts the prices Medicare uses to pay hospitals and many other health care providers. ObamaCare could force one in six hospitals to stop accepting Medicare patients. we will ration with our eyes open.You can't get medications. You are left waiting on life saving procedures. You must wait for quality of life procedures that are medically needed. 5 million Canadians have no health insurance and the wait is 5 years for a primary care physician.
What the Government Shutdown Means to the Med Device Industry?EMMAIntl
On December 22nd, 2018, the Federal Government went into a partial shutdown. Forty one percent of the FDA staff has been furloughed, which means that out of 17,397 FDA staff members, only 10,344 members have been retained for work. The number of furloughed employees may increase as the shutdown progresses...
Safer Technologies Program for Medical DevicesEMMAIntl
FDA has introduced a new program for medical devices and for device led combination products. Under this program are devices that do not qualify to be cleared via the breakthrough program but significantly improve the safety of the currently available options that treat diseases that are non-life threatening...
NEMEA\'s library of authority documents. To create a survey or audit, log into the Compliance Centre, select the type of audit and choose your authority document. It could not be easier!
Whenever there is a public health emergency, such as the Zika virus in 2016 or the current novel coronavirus, there is a rush to get diagnostic tests and other medical products to detect and treat the emergency available quickly. Given that dealing with the FDA isn’t usually a quick transaction, there is a provision in place called the Emergency Use Authorization (EUA) which allows the use of unapproved medical products when there are no other adequate or available alternatives...
CVS Aetna "Revolutionizing Consumer Health Care"TrustRobin
Align incentives and collaborate with providers to:
• Help providers build the health experience of the future
• Integrate data into EMR/provider workflows
• Improve member health
• Deliver a differentiated patient experience
• Improve quality and efficiency
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...Epstein Becker Green
Presented by Mark S. Armstrong, Member of the Firm, Epstein Becker Green.
http://www.ebglaw.com/investment-banks-private-equity/private-equity-resource-center/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Digital Health Devices and Clinical Trials – Wearables Crash Course Webinar S...Epstein Becker Green
Epstein Becker Green Webinar with Attorney Daniel G. Gottlieb - Wearables Crash Course Webinar Series - June 14, 2016.
Wearables can collect valuable data in clinical trials. However, there is not a lot of clarity on how wearables are regulated. This session will help you understand why this uncertainty exists and provide you with strategies for navigating these muddy regulatory waters.
See http://www.ebglaw.com/events/digital-health-devices-and-clinical-trials-wearables-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...Epstein Becker Green
Moderated by Robert F. Atlas, President/Strategic Advisor of EBG Advisors, this webinar will inform both plans and providers of payment and notice protections when enrollees receive services from out-of-network providers.
Learn about federal and state efforts to protect consumers from unexpected out-of-network charges. Panelists will explain federal protections under the Affordable Care Act as well as specific legislative approaches taken by numerous states.
Featured panelists:
* Helaine I. Fingold, Senior Counsel
* Jackie Selby, Member of the Firm
* Basil H. Kim, Associate
* Lesley R. Yeung, Associate
See also http://www.ebglaw.com/events/out-of-network-billing-the-impact-of-consumer-protection-measures-on-health-plans-and-providers/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Providers seeing a 2 percent payment decrease on their Remittance Advice (RA) is due to a mandatory sequestration payment reduction. Claim adjustment reason code (CARC) 253 is used to report the sequestration reduction.
Back in May, the FDA announced its intention to re-start domestic routine inspections (which you can read more about in our blog here). Last week, the FDA announced that it is planning to restart some on-site surveillance activities the week of July 20. This comes four months after putting all routine domestic inspections on hold due to COVID-19. In line with its update in May, the agency reiterated it will be following CDC guidelines to implement the plan safely, keeping the safety of FDA and industry staff as the top priority...
ACA Information Reporting on Forms 1094 and 1095 B&C: Getting Ready for 2017 ...Epstein Becker Green
Join Michelle Capezza, Member of the Firm at Epstein Becker Green, and Howard M. Gerver, President of ACA Managed Services, for a conversation regarding best practices for ACA information reporting, addressing such topics as:
* Data collection and troubleshooting
* Addressing invalid names and social security numbers
* Determining whether an offer of qualifying coverage was made and assigning the correct code
* Employee Status Codes
* Misclassified workers
* Approaching corrections and penalties
* New Developments
With the first year of ACA information reporting completed, it is time to prepare for 2016 information reporting that will be filed in 2017. As the potential for IRS audits and penalties loom, explore some of the pitfalls and lessons learned from the recent inaugural process in order to streamline and improve your compliance with the requirements.
Webinar recorded on September 8, 2016.
http://www.ebglaw.com/events/aca-information-reporting-on-forms-1094-and-1095-bc-getting-ready-for-2017-webinar/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
The Road Ahead for Health Care ComplianceFrank Sheeder
The Health Care Reform Package has significant implications for health care compliance professionals. This presentation addresses many of the issues that they will be compelled to face right away, and in the next several years.
Evaluate California Pharma & Biotech Innovation Outlook 2017Evaluate Ltd
Report Highlights Include
• The Top of the California Rankings in 2022
• Where California Companies are Investing in the Future – Pipeline and Approvals
• Where California Companies are Investing in the Future – Venture Financing and M&A
CVS Aetna "Revolutionizing Consumer Health Care"TrustRobin
Align incentives and collaborate with providers to:
• Help providers build the health experience of the future
• Integrate data into EMR/provider workflows
• Improve member health
• Deliver a differentiated patient experience
• Improve quality and efficiency
Recent Investigation and Enforcement Trends: 2016 Compliance and TPL Focused ...Epstein Becker Green
Presented by Mark S. Armstrong, Member of the Firm, Epstein Becker Green.
http://www.ebglaw.com/investment-banks-private-equity/private-equity-resource-center/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Digital Health Devices and Clinical Trials – Wearables Crash Course Webinar S...Epstein Becker Green
Epstein Becker Green Webinar with Attorney Daniel G. Gottlieb - Wearables Crash Course Webinar Series - June 14, 2016.
Wearables can collect valuable data in clinical trials. However, there is not a lot of clarity on how wearables are regulated. This session will help you understand why this uncertainty exists and provide you with strategies for navigating these muddy regulatory waters.
See http://www.ebglaw.com/events/digital-health-devices-and-clinical-trials-wearables-crash-course-webinar-series/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Out-of-Network Billing: The Impact of Consumer Protection Measures on Health ...Epstein Becker Green
Moderated by Robert F. Atlas, President/Strategic Advisor of EBG Advisors, this webinar will inform both plans and providers of payment and notice protections when enrollees receive services from out-of-network providers.
Learn about federal and state efforts to protect consumers from unexpected out-of-network charges. Panelists will explain federal protections under the Affordable Care Act as well as specific legislative approaches taken by numerous states.
Featured panelists:
* Helaine I. Fingold, Senior Counsel
* Jackie Selby, Member of the Firm
* Basil H. Kim, Associate
* Lesley R. Yeung, Associate
See also http://www.ebglaw.com/events/out-of-network-billing-the-impact-of-consumer-protection-measures-on-health-plans-and-providers/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
Providers seeing a 2 percent payment decrease on their Remittance Advice (RA) is due to a mandatory sequestration payment reduction. Claim adjustment reason code (CARC) 253 is used to report the sequestration reduction.
Back in May, the FDA announced its intention to re-start domestic routine inspections (which you can read more about in our blog here). Last week, the FDA announced that it is planning to restart some on-site surveillance activities the week of July 20. This comes four months after putting all routine domestic inspections on hold due to COVID-19. In line with its update in May, the agency reiterated it will be following CDC guidelines to implement the plan safely, keeping the safety of FDA and industry staff as the top priority...
ACA Information Reporting on Forms 1094 and 1095 B&C: Getting Ready for 2017 ...Epstein Becker Green
Join Michelle Capezza, Member of the Firm at Epstein Becker Green, and Howard M. Gerver, President of ACA Managed Services, for a conversation regarding best practices for ACA information reporting, addressing such topics as:
* Data collection and troubleshooting
* Addressing invalid names and social security numbers
* Determining whether an offer of qualifying coverage was made and assigning the correct code
* Employee Status Codes
* Misclassified workers
* Approaching corrections and penalties
* New Developments
With the first year of ACA information reporting completed, it is time to prepare for 2016 information reporting that will be filed in 2017. As the potential for IRS audits and penalties loom, explore some of the pitfalls and lessons learned from the recent inaugural process in order to streamline and improve your compliance with the requirements.
Webinar recorded on September 8, 2016.
http://www.ebglaw.com/events/aca-information-reporting-on-forms-1094-and-1095-bc-getting-ready-for-2017-webinar/
These materials have been provided for informational purposes only and are not intended and should not be construed to constitute legal advice. The content of these materials is copyrighted to Epstein Becker & Green, P.C. ATTORNEY ADVERTISING.
The Road Ahead for Health Care ComplianceFrank Sheeder
The Health Care Reform Package has significant implications for health care compliance professionals. This presentation addresses many of the issues that they will be compelled to face right away, and in the next several years.
Evaluate California Pharma & Biotech Innovation Outlook 2017Evaluate Ltd
Report Highlights Include
• The Top of the California Rankings in 2022
• Where California Companies are Investing in the Future – Pipeline and Approvals
• Where California Companies are Investing in the Future – Venture Financing and M&A
Impact of the Government Shutdown on Synchrogenix FDA-regulated ClientsDarshan Kulkarni
As of Dec 22nd, some 800,000 federal workers either furloughed or working without pay. Will this compromise the FDA's mission to protect public health?
FDA Extends the Timeline to Respond to Additional Information RequestsEMMAIntl
The FDA revised its guidance document ‘Effects of the COVID-19 Public Health Emergency on Formal Meetings and User Fee Applications for Medical Devices — Questions and Answers’ which was originally released in June, to give device sponsors additional time in responding to FDA’s requests for additional information for device applications that are on hold.
At the onset of the pandemic, FDA realized that device makers were faced with unprecedented challenges related to supply chain issues, human resources, etc., while on the other hand, the FDA saw a surge in EUA activities which required shifting of staff resources at the FDA. During this time, the FDA released a guidance document to extend the timeline for responding to the FDA’s requests for submissions/applications that were put on hold. The originally released guidance document provided a sigh of relief to device sponsors by allowing an additional 90 day period beyond the response date initially assigned...
Earlier this year, the Department of Health and Human Services proposed exempting 84 types of Class II devices from 510(k) requirements, which stemmed from the relaxed regulations for the COVID-19 public health emergency. After reviewing adverse event data from both before and after the relaxed pandemic regulations, the FDA began to examine its current market authorization process for medical devices...
1Group Term Policy Modification Paper2H.R. 6201 Families .docxdurantheseldine
1
Group Term Policy Modification Paper
2
H.R. 6201 Families First Coronavirus Response Act
Group Term Policy Modification Paper:H.R. 6201 Families First Coronavirus Response Act
H.R. 6201 Families First Coronavirus Response Act
Introduction
The outbreak of the coronavirus disease in Wuhan, China, in December 2020 and its spread to other parts of the world has led to significant changes not only in the United States but throughout the world. Globally, the public sector and policymakers have faced the biggest test in generations. New policies have been necessitated by livelihoods and lives hanging in a delicate and terrible balance. Some of the policies put in place are meant to leverage collapsing economies, health cruses, political and social disruption (Washington State Department of Social and Health Services, 2020). The world economy has taken a nosedive. Some international bodies such as WHO and WTO have been working to mitigate the pandemic's adverse effects on a global scale. The script is not different in the national, state, and local effects of coronavirus disease. Both Federal and State Governments have been struggling to contain the spread and impact of the disease on the economy. The pandemic has scaled down economic activities. The U.S. economy has slowed down significantly. Unemployment is growing rapidly. The adverse effects have led to the enactment of several policies to mitigate the impacts (Washington State Department of Social and Health Services, 2020). One of the laws that have been enacted to mitigate the adverse effects of coronavirus disease on the Americans is The Families First Coronavirus Response Act (H.R. 6201). This paper evaluates The H.R. 6201 and how it mitigates coronavirus disease's adverse effects on the Americans. That provides funding for Americans to be able to meet their basic financial needs. It increases funding for food stamps, paid leave (14 days) for those employees experiencing effects of coronavirus disease outbreak, and provides funding for free coronavirus testing areas. Additionally, the bill provides funding to mitigate the ongoing economic consequences of the pandemic, protect front-line health workers, expand food assistance to the vulnerable families and children, and support strong unemployment benefits, among other provisions. For our term policy modification paper we have proposed the following change: Propose Change
A change in our opinion is for the second stimulus to have been passed to all Americans because as of today people are still without a job and seeking. Those workers who have stayed with their jobs have been reduced in their benefits.
Companies with employees less than 500 should be exempted from paying leave to their employees while big companies having more than 500 employees should provide pay leaf otherwise the bill is unfair to small business (Hamilton, 2020)
The Act requires that the employers should provide Emergency Pa.
OMBUD THE PHYSICIAN PAYMENT SUNSHINE ACT AND ESIGNATURESDocuSign
Subsequent to the passage of the Patient Protection and Affordable Care Act, also called Obamacare, pharmaceutical and medical device manufacturers could face fines for failing to correctly report payments made to physicians. This paper discusses outstanding questions about best practices for streamlining and reporting on the process.
COVID-19, the disease caused by the novel coronavirus SARS-CoV-2, was officially declared a pandemic back in early March. Since then the medical device industry has been trying to adjust to the far-reaching obstacles presented by this public health emergency, such as global supply chain shortages, social distancing risks, and more. As such, the FDA has also had to make significant and unprecedented changes to mitigate risks and make sure that public safety is continuously protected. In this paper, we will explore the FDA’s response to COVID-19 cohesively, looking at how the agency has had to modify some of its processes and policies, relax regulatory requirements, and what the future of the regulatory-landscape looks like for the medical device industry post-COVID-19...
California consumer privacy act and its impact on california employersmosmedicalreview
The CCPA could have major implications for employers, the workers’ comp industry, lawyers, medical record retrieval companies serving lawyers, & insurers.
Many attempts have been made to produce a long-term, cost-effective, and biocompatible scaffold; however, most attempts fail to achieve this. An example would be collagen-based scaffolds. Collagen is the body’s most abundant protein and is thus highly biocompatible. Unfortunately, collagen-based scaffolds have disappointing long-term properties including poor shape retention and mechanical strength. Many types of these bio-scaffolds exist including protein-based, carbohydrate-based, polymer-based, or a combination of these...
Stability Testing of Pharmaceuticals and SupplementsEMMAIntl
Whether you are working on a prescription drug, over-the-counter (OTC) drug, or even a dietary supplement, stability testing is required depending on the location of registration and agencies involved in its approval. Stability testing is the method of testing a product's safety, efficacy, and chemical composition after a set period...
Millions in the United States alone have an allergic condition, with many of these allergies being related to food. According to the Food Allergy Research & Education organization (FARE) 32 million Americans have food allergies. Of those 32 million, 200,000 require emergency medical care for allergic reactions from those foods. A common misconception is that food intolerance is a food allergy when in actuality that is its own unique category...
The field of biomedical engineering is a new, widely researched, and well-funded industry that aims to tackle problems in medicine and health by providing engineered solutions. These solutions might be delivered in the form of electrical hardware, chemicals, or even software. Given the extensive range of applications that exist in the medical device industry, the field is continuously accelerating its innovations in technology via an abundance of research and innovation outlets in countless interrelated fields. One of the many fields that are fundamentally fueling the growth of the biomedical industry is material science...
Investigating Ketamine for Parkinson’s DiseaseEMMAIntl
In May 2021, the FDA approved an Investigational New Drug (IND) application from PharmaTher Holdings Ltd., to proceed with a Phase Two clinical trial. PharmaTher Holdings Ltd. is a psychedelics biotech organization that focuses on research and development, and commercialization of psychedelics to treat pain and neurological disorders, and mental illnesses. This company is headquartered in Vancouver, Canada...
Aduhelm, an Accelerated Approval for Alzheimer’sEMMAIntl
Alzheimer’s disease is the most common cause of dementia, especially in patients aged 65 and older1. Alzheimer’s disease is a neurodegenerative disease that has a direct correlation to age: as age increases, the likelihood of developing Alzheimer’s increases as well. Alzheimer’s has long been a subject of discussion in the pharmaceutical industries and, until the FDA’s recent accelerated approval of Aduhelm earlier this month, the most recent treatment approved for Alzheimer’s was in 2003, almost two decades ago. The FDA’s approval of Aduhelm represents the first-of-its-kind treatment and is the first therapy that aims to interrupt the underlying physiological pathway of Alzheimer’s, rather than simply attempt to treat its symptoms...
Every June 14th, the World Health Organization (WHO) hosts World Blood Donor Day to raise awareness all over the globe for how crucial the need for safe blood is in the healthcare industry. In the US and Canada alone, 43,000 pints of blood are used each day for life-saving procedures and treatments...
Starting in Summer 2021, a new type of COVID vaccine could be available. Known as a protein subunit vaccine, this vaccine contains a spike protein that the other three vaccines are missing. The other vaccines, Pfizer, Moderna, and Johnson & Johnson, contain instructions for the spike protein but do not actually include the spike protein in the vaccination. The three vaccines allow our cell bodies to make the protein up for itself...
June 14th through the 20th is Men’s Health Week, which is a great opportunity to heighten awareness for men’s depression. There is a theme in society applicable to most men as they tend to internalize depressive thoughts, not allowing for a proper diagnosis. There are four major reasons men do not reach out for help with their depression: failure to recognize the depression consuming them, downplaying signs and symptoms, reluctance to converse about their feelings with others, and resisting mental health treatment...
Celebrating Pride Month at EMMA InternationalEMMAIntl
June 1 started the celebration of Pride Month, which commemorates Lesbian, Gay, Bisexual, and Transgender members. Celebrating Pride Month is also more than celebrating members of the LGBTQIA+, this month is also about recognizing that diversity fuels innovation and collaboration among a variety of industries, including the life sciences...
Growth and Integration of ML/AI in BiotechEMMAIntl
The biotechnology and pharmaceutical industries are heavily reliant on collecting, storing, and analyzing data for both R&D as well as production purposes. The large, countless, and rapidly growing sets of data are critical for researchers and scientists to accelerate progress in the medical industry. As our technologies advance and our capacity to store data continue to increase, we must continue to find new ways to efficiently analyze data. Researchers at the European Bioinformatics Institute (EMBL-EBI) have determined that nucleotide and proteomics data is growing at an exponential rate, with the amount of data stored on their servers doubling each year...
Quality Function Deployment, or QFD, is a decades-old methodology focused on the voice of the customer. It was initially developed in Japan in the 1960s but was popularized in the US by the automotive industry in the 1980s . QFD is a tool often leveraged by Total Quality Management (TQM), which is a quality principle that customers define quality and subsequently should be prioritized at all stages of the product, both pre-and post-production...
New digital health technology is coming out every day and is changing the course of the MedTech industry as we know it. Many physicians are making the transition to using these digital health devices and technologies to improve patient care and outcomes. Some of this increase can be attributed to COVID-19 of course as it enabled them to provide care for patients remotely. However, many of these digital health devices and technologies have been around for a bit, so what caused the hesitation in adapting them sooner and what are some of the great perks of this new wave of medical care?
Immune Systems After the COVID-19 PandemicEMMAIntl
Everyone has heard that immune systems weaken when they are sheltered, but is that really the case? As we are now over one year into lockdowns and social distancing, many are becoming concerned that after the pandemic immune systems are going to falter after being isolated for such a long period, and many adults are concerned to resume a “normal” life due to this...
Stability Testing Requirements for PharmaceuticalsEMMAIntl
Deciding how and when to conduct stability tests on your new drug can be challenging. Stability tests provide evidence data on how the quality of a drug substance or drug product varies with time under the influence of a variety of environmental factors. It also establishes a retest period for the drug substance or a shelf life for the drug product and recommended storage conditions...
EMMA International is continuing to celebrate Women’s Health Week! While there are so many reasons Women’s Health Week is important, one of the best things to come out of this week is the attention it brings and the reminders that we should all consider our health and take steps to ensure a healthy future...
Happy National Women’s Health Week! In honor of this week bringing light to important women’s health issues, I wanted to walk through a brief history of innovations that shaped one of the largest facets of women’s health – reproductive health...
In the work from home era, we all realized how important it is to digitize our important documents and what a lifesaver digital signatures are. With everything now getting electronically stored, electronic signatures and documentation are slowly replacing the paper-based system. That means we must now get ready to expand our digital storage plans rather than buying new filing cabinets...
Considerations for Biocompatibility EvaluationEMMAIntl
Biocompatibility is one of the most critical performance studies that manufacturers need to perform as part of their product development process. ISO 10993-5 and ISO 10993-10 are FDA-recognized standards for biocompatibility. Whether you perform these studies in-house or send out samples to a third-party lab the protocol for biocompatibility assessment must be conducted in accordance with ISO 10993...
Restoring the Earth for a Healthier FutureEMMAIntl
Today marks the 52nd anniversary of the birth of the true modern environmental movement, however, you probably know it as Earth Day. Early in the pandemic, many hoped that the lockdowns would help the Earth heal as people began to stay home, stopped commuting, and some factories even had paused production. Unfortunately, as things are beginning to open back up emissions are on the rise again and we need to continue to think about the future consequences...
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
1. The End of the Longest Government
Shutdown
By: Nikita Angane, MS
The government has temporarily “re-opened” until Feb 15th after the longest government
shutdown in US history that lasted for 35 days.
Here’s what’s going to happen:
Some FDA officials carried out inspections and other critical activities without being paid to
continue to respond to threats to public health. Around 800,000 federal workers have been
promised a back pay.i
The resumed activities amid the shutdown were funded by the carryover user fees of certain
review applications. These applications were experiencing delays in their review and now pose
as a backlog since the industry will now start submitting new applications after a long wait.
FDA has started accepting new pre-market review applications but of course, the timelines of the
review will suffer because of the backlog.
The shutdown has already caused lasting damage in other agencies as well. As for the FDA, the
agency will still face a backlog of applications and other regulatory activities that will continue
for the near future.ii Medical device manufacturers who plan on submitting a 510(k) or a PMA
anytime soon will face delayed clearances for their devices.
We are closely monitoring the activities in D.C. and will keep you updated on any changes that
will impact the Medical Device industry.
If you need help in preparing your 510(k) or PMA, please call us at 248-987-4497 or email us at
info@emmainternational.com.
i Vox (Jan 2019) The government is reopened (for now). But the recovery process may take a while. Retrieved on
02/07/2019 from https://www.vox.com/2019/1/26/18198630/government-shutdown-recovery
ii Health Law Advisor (Jan 2019) Not Business as Usual: The Government Shutdown’s Impact at FDA. Retrieved on
02/07/2019 from https://www.healthlawadvisor.com/2019/01/22/not-business-as-usual-the-government-shutdowns-
impact-at-fda/